September 20, 2026

Patient Advocacy and Support

The Data Gap in Oncology: METAvivor and the Alliance for Breast Cancer Policy Target FY 2027 Appropriations for Registry Modernization the-data-gap-in-oncology-metavivor-and-the-alliance-for-breast-cancer-policy-target-fy-2027-appropriations-for-registry-modernization

The Data Gap in Oncology: METAvivor and the Alliance for Breast Cancer Policy Target FY 2027 Appropriations for Registry Modernization

Muslim August 20, 2026
Main Facts: Addressing the "Invisible" Population in Cancer Statistics In a decisive move to bridge a critical...
Read More Read more about The Data Gap in Oncology: METAvivor and the Alliance for Breast Cancer Policy Target FY 2027 Appropriations for Registry Modernization
Bridging the Gap in Canadian Oncology: The Launch of National Clinical Consensus Recommendations for Breast Cancer bridging-the-gap-in-canadian-oncology-the-launch-of-national-clinical-consensus-recommendations-for-breast-cancer

Bridging the Gap in Canadian Oncology: The Launch of National Clinical Consensus Recommendations for Breast Cancer

Nila Kartika Wati August 19, 2026
The landscape of breast cancer treatment is currently undergoing a paradigm shift, characterized by a transition from...
Read More Read more about Bridging the Gap in Canadian Oncology: The Launch of National Clinical Consensus Recommendations for Breast Cancer
The Long Arc of Progress: How the Evolution of Breast Cancer Treatment is Ushering in the Era of Precision Medicine the-long-arc-of-progress-how-the-evolution-of-breast-cancer-treatment-is-ushering-in-the-era-of-precision-medicine

The Long Arc of Progress: How the Evolution of Breast Cancer Treatment is Ushering in the Era of Precision Medicine

Muslim August 18, 2026
For millennia, the diagnosis of breast cancer was often synonymous with a death sentence. Today, however, we...
Read More Read more about The Long Arc of Progress: How the Evolution of Breast Cancer Treatment is Ushering in the Era of Precision Medicine
Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal LYNKUET® for Breast Cancer Patients bridging-the-gap-in-survivorship-health-canada-authorizes-non-hormonal-lynkuet-for-breast-cancer-patients

Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal LYNKUET® for Breast Cancer Patients

Laily UPN August 17, 2026
TORONTO – In a move signaling a paradigm shift in supportive oncology, Health Canada has officially expanded...
Read More Read more about Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal LYNKUET® for Breast Cancer Patients
A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer a-new-horizon-in-oncology-fda-approves-sacituzumab-govitecan-for-metastatic-triple-negative-breast-cancer

A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

Laily UPN August 17, 2026
The landscape of breast cancer treatment has undergone a seismic shift following the U.S. Food and Drug...
Read More Read more about A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

You may have missed

mastering-the-gravity-defying-flow-the-art-of-the-ashtanga-jump-back

Mastering the Gravity-Defying Flow: The Art of the Ashtanga Jump-Back

Ammar Sabilarrohman September 20, 2026
cultivating-prosperity-the-bridges-engine-and-the-future-of-rural-agriculture-1

Cultivating Prosperity: The BRIDGES Engine and the Future of Rural Agriculture

Basiran September 20, 2026
a-lifesaving-breakthrough-for-brca-carriers-cambridge-study-confirms-bilateral-salpingo-oophorectomy-significantly-reduces-early-death-risk

A Lifesaving Breakthrough for BRCA Carriers: Cambridge Study Confirms Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk

Laily UPN September 20, 2026
the-pan-viral-frontier-can-cocrystal-pharma-rewrite-the-rules-of-antiviral-development-1

The Pan-Viral Frontier: Can Cocrystal Pharma Rewrite the Rules of Antiviral Development?

Rifan Muazin September 20, 2026